Eucommia ulmoides Oliv. bark. attenuates 6-hydroxydopamine-induced neuronal cell death through inhibition of oxidative stress in SH-SY5Y cells

Journal of Ethnopharmacology

Volumn 152, Issue 1, 2014, Pages 173-182

  Kwon, Seung Hwan ^a   Ma, Shi Xun ^a   Hong, Sa Ik ^a   Kim, Sun Yeou ^b   Lee, Seok Yong ^a   Jang, Choon Gon ^a  

^a Sungkyunkwan University   (South Korea)

^b Gachon University   (South Korea)

Author keywords

6 Hydroxydopamine; Apoptosis; Eucommia ulmoides Oliv. bark; Mitochondrial membrane dysfunction; Oxidative stress; Parkinson's disease

Indexed keywords

CHLOROGENIC ACID; EUCOMMIA ULMOIDES EXTRACT; GLYCOGEN SYNTHASE KINASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; OXIDOPAMINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; BARK; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ENZYME PHOSPHORYLATION; EUCOMMIACEAE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE; NERVE CELL NECROSIS; NEUROPROTECTION; OXIDATIVE STRESS; PARKINSON DISEASE; TU CHUNG;

EUCOMMIA ULMOIDES;

6-HYDROXYDOPAMINE; APOPTOSIS; EUCOMMIA ULMOIDES OLIV. BARK; MITOCHONDRIAL MEMBRANE DYSFUNCTION; OXIDATIVE STRESS; PARKINSON'S DISEASE;

APOPTOSIS; CELL DEATH; CELL LINE, TUMOR; EUCOMMIACEAE; HUMANS; MITOCHONDRIA; NEUROBLASTOMA; NEURONS; NEUROPROTECTIVE AGENTS; NF-KAPPA B; OXIDATIVE STRESS; OXIDOPAMINE; PHOSPHORYLATION; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES;

EID: 84893875778     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2013.12.048     Document Type: Article

References (44)

1. L. Bertram, and R.E. Tanzi Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses Nat. Rev. Neurosci. 9 2008 768 778
2. D. Blum, S. Torch, N. Lambeng, M. Nissou, A.L. Benabid, R. Sadoul, and J.M. Verna Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease Prog. Neurobiol. 65 2001 135 172 (Pubitemid 32524182)
3. J. Bove, and C. Perier Neurotoxin-based models of Parkinson's disease Neuroscience 211 2012 51 76
4. J. Chao, H. Li, K.W. Cheng, M.S. Yu, R.C. Chang, and M. Wang Protective effects of pinostilbene, a resveratrol methylated derivative, against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells J. Nutr. Biochem. 21 2010 482 489
5. G. Chen, K.A. Bower, C. Ma, S. Fang, C.J. Thiele, and J. Luo Glycogen synthase kinase 3beta (GSK3β) mediates 6-hydroxydopamine-induced neuronal death FASEB J. 18 2004 1162 1164 (Pubitemid 39561557)
6. T.M. Dawson, and V.L. Dawson Neuroprotective and neurorestorative strategies for Parkinson's disease Nat. Neurosci. 2002 5 (Supplement, S1058-S1061)
7. D.M. de Oliveria, G. Barreto, D.V. De Andrade, E. Saraceno, L. Aon-Bertolino, F. Capani, R. Dos Santos El Bacha, and L.D. Giraldez Cytoprotective effect of Valeriana officinalis extract on an in vitro experimental model of Parkinson disease Neurochem. Res. 34 2009 215 220
8. T.P. Devasagayam, J.C. Tilak, K.K. Boloor, K.S. Sane, S.S. Ghaskadbi, and R.D. Lele Free radicals and antioxidants in human health: current status and future prospects J. Assoc. Physicians India 52 2004 794 804 (Pubitemid 41279997)
9. M. Driscoll, and B. Gerstbrein Dying for a cause: invertebrate genetics takes on human neurodegeneration Nat. Rev. Genet. 4 2003 181 194 (Pubitemid 36267889)
10. H. Elkon, E. Melamed, and D. Offen 6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's disease Cell. Mol. Neurobiol. 21 2001 771 781 (Pubitemid 34538869)
11. X. Fan, S. Lin, C. Zhu, Y. Liu, J. Hu, X. Chen, W. Wang, N. Chen, and J. Shi Aromatic constituents of Heteroplexis micocephal and their bioactivities Zhongguo. Zhong. Yao. Za. Zhi. 36 2011 48 56
12. G. Filomeni, J.P. Bolanos, and P.G. Mastroberardino Redox status and bioenergetics liaison in cancer and neurodegeneration Int. J. Cell Biol. 2012 2012 659645
13. A. Ghosh, K. Chandran, S.V. Kalivendi, J. Joseph, W.E. Antholine, C.J. Hillard, A. Kanthasamy, and B. Kalyanaraman Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model Free Radical Biol. Med. 49 2010 1674 1684
14. A. Ghosh, A. Roy, X. Liu, J.H. Kordower, E.J. Mufson, D.M. Hartley, S. Ghosh, R.L. Mosley, H.E. Gendelman, and K. Pahan Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease Proc. Natl. Acad. Sci. U. S. A. 104 2007 18754 18759 (Pubitemid 350210769)
15. M. Hashimoto, E. Rockenstein, L. Crews, and E. Masliah Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases Neuromolecular. Med. 4 2003 21 36
16. S. Hunot, B. Brugg, D. Ricard, P.P. Michel, M.P. Muriel, M. Ruberg, B.A. Faucheux, Y. Agid, and E.C Hirsch Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease Proc. Natl. Acad. Sci. U. S. A. 94 1997 7531 7536 (Pubitemid 27345350)
17. L. Jiang, Z. Wang, H.W. Zhu, H.Y. Di, H. Li, Y.Y. Zhang, and D.F. Chen Beneficial effect of Eucommia polysaccharides on systemic lupus erythematosus-like syndrome induced by Campylobacter jejuni in BALB/c mice Inflammation 34 2011 402 411
18. M.K. Kim, S.C. Kim, J.I. Kang, H.J. Boo, J.W. Hyun, Y.S. Koh, D.B. Park, E.S. Yoo, J.H. Kang, and H.K. Kang Neuroprotective effects of Carpinus tschonoskii MAX on 6-hydroxydopamine-induced death of PC12 cells Biomolecules and Ther. 18 2010 454 462
19. C.Y. Kwan, C.X. Chen, T. Deyama, and S. Nishibe Endothelium-dependent vasorelaxant effects of the aqueous extracts of the Eucommia ulmoides Oliv. leaf and bark: implications on their antihypertensive action Vascul. Pharmacol. 40 2003 229 235 (Pubitemid 38402121)
20. S.H. Kwon, S.I. Hong, Y.H. Jung, M.J. Kim, S.Y. Kim, H.C. Kim, S.Y. Lee, and C.G. Jang Lonicera japonica THUNB. protects 6-hydroxydopamine-induced neurotoxicity by inhibiting activation of MAPKs, PI3K/Akt, and NF-kappaB in SH-SY5Y cells Food Chem. Toxicol. 50 2012 797 807
21. S.H. Kwon, M.J. Kim, S.X. Ma, I.J. You, J.Y. Hwang, J.H. Oh, S.Y. Kim, H.C. Kim, S.Y. Lee, and C.G. Jang Eucommia ulmoides Oliv. Bark. protects against hydrogen peroxide-induced neuronal cell death in SH-SY5Y cells J. Ethnopharmacol. 142 2012 337 345
22. S.H. Kwon, H.K. Lee, J.A. Kim, S.I. Hong, S.Y. Kim, T.H. Jo, Y.I. Park, C.K. Lee, Y.B. Kim, S.Y. Lee, and C.G. Jang Neuroprotective effects of Eucommia ulmoides Oliv. Bark on amyloid beta(25-35)-induced learning and memory impairments in mice Neurosci. Lett. 487 2011 123 127
23. M.K. Lee, S.Y. Cho, D.J. Kim, J.Y. Jang, K.H. Shin, S.A. Park, E.M. Park, J.S. Lee, M.S. Choi, and M.J. Kim Du-zhong (Eucommia ulmoides Oliv.) cortex water extract alters heme biosynthesis and erythrocyte antioxidant defense system in lead-administered rats J. Med. Food 8 2005 86 92 (Pubitemid 40617043)
24. J. Lotharius, L.L. Dugan, and K.L. O'Malley Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons J. Neurosci. 19 1999 1284 1293 (Pubitemid 29088911)
25. L.F. Luo, W.H. Wu, Y.J. Zhou, J. Yan, G.P. Yang, and D.S. Ouyang Antihypertensive effect of Eucommia ulmoides Oliv. extracts in spontaneously hypertensive rats J. Ethnopharmacol. 129 2010 238 243
26. J.C. Mayo, R.M. Sainz, D.X. Tan, I. Antolin, C. Rodriguez, and R.J. Reiter Melatonin and Parkinson's disease Endocrine 27 2005 169 178 (Pubitemid 41558449)
27. P.I. Moreira, X. Zhu, X. Wang, H.G. Lee, A. Nunomura, R.B. Petersen, G. Perry, and M.A. Smith Mitochondria: a therapeutic target in neurodegeneration Biochim. Biophys. Acta 1802 2010 212 220
28. R.L. Mosley, E.J. Benner, I. Kadiu, M. Thomas, M.D. Boska, K. Hasan, C. Laurie, and H.E. Gendelman Neuroinflammation, oxidative stress and the pathogenesis of Parkinson's disease Clin. Neurosci. Res. 6 2006 261 281 (Pubitemid 44849177)
29. K. Nakaso, S. Ito, and K. Nakashima Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells Neurosci. Lett. 432 2008 146 150
30. A. Nunomura, P.I. Moreira, H.G. Lee, X. Zhu, R.J. Castellani, M.A. Smith, and G. Perry Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases CNS Neurol. Disord. Drug Targets 6 2007 411 423 (Pubitemid 351486255)
31. 2-terminal kinase signaling cascades is required for induction of apoptosis in Parkinson's disease cybrids Mol. Cell. Neurosci. 28 2005 452 461 (Pubitemid 40311849)
32. S. Reuter, S.C. Gupta, M.M. Chaturvedi, and B.B. Aggarwal Oxidative stress, inflammation, and cancer: how are they linked? Free Rad. Biol. Med. 49 2010 1603 1616
33. Y. Sagi, S. Mandel, T. Amit, and M.B. Youdim Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism Neurobiol. Dis. 25 2007 35 44 (Pubitemid 44765215)
34. K. Sapkota, S. Kim, S.E. Park, and S.J. Kim Detoxified extract of Rhus verniciflua stokes inhibits rotenone-induced apoptosis in human dopaminergic cells, SH-SY5Y. Cell Mol. Neurobiol. 31 2011 213 223
35. W. Shen, R. Qi, J. Zhang, Z. Wang, H. Wang, C. Hu, Y. Zhao, M. Bie, Y. Wang, Y. Fu, M. Chen, and D. Lu Chlorogenic acid inhibits LPS-induced microglial activation and improves survival of dopaminergic neurons Brain. Res. Bull. 88 2012 487 494
36. R.A. Smith, and M.P. Murphy Mitochondria-targeted antioxidants as therapies Discov. Med. 11 2011 106 114
37. J.X. Song, P.C. Shaw, C.W. Sze, Y. Tong, X.S. Yao, T.B. Ng, and Y.B. Zhang Chrysotoxine, a novel bibenzyl compound, inhibits 6-hydroxydopamine induced apoptosis in SH-SY5Y cells via mitochondria protection and NF-kappaB modulation Neurochem. Int. 57 2010 676 689
38. H.H. Szeto Mitochondria-targeted peptide antioxidants: novel neuroprotective agents AAPS J. 8 2006 E521 E531
39. M. Teraoka, K. Nakaso, C. Kusumoto, S. Katano, N. Tajima, A. Yamashita, T. Zushi, S. Ito, and T. Matsura Cytoprotective effect of chlorogenic acid against alpha-synuclein-related toxicity in catecholaminergic PC12 cells J. Clin. Biochem. Nutr. 51 2012 122 127
40. B. Uttara, A.V. Singh, P. Zamboni, and R.T. Mahajan Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options Curr. Neuropharmacol. 7 2009 65 74
41. W. Wang, Y. Yang, C. Ying, W. Li, H. Ruan, X. Zhu, Y. You, Y. Han, R. Chen, Y. Wang, and M. Li Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity Neuropharmacology 52 2007 1678 1684 (Pubitemid 46843143)
42. B. Xiang, X. Fei, W. Zhuang, Y. Fang, Z. Qin, and Z. Liang Cathepsin L is involved in 6-hydroxydopamine induced apoptosis of SH-SY5Y neuroblastoma cells Brain. Res. 1387 2011 29 38
43. H. Yuan, J.C. Zheng, P. Liu, S.F. Zhang, J.Y. Xu, and L.M. Bai Pathogenesis of Parkinson's disease: oxidative stress, environmental impact factors and inflammatory processes Neurosci. Bull. 23 2007 125 130 (Pubitemid 46797510)
44. Y. Zhou, M. Liang, W. Li, K. Li, P. Li, Y. Hu, and Z. Yang Protective effects of Eucommia ulmoides Oliv. bark and leaf on amyloid beta-induced cytotoxicity Environ. Toxicol. Pharmacol. 28 2009 342 349